Complement Therapeutics GmbH (CTx) is a German-headquartered biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade.
Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for GA, a leading cause of blindness. Additional programs will evaluate potential therapeutic opportunities in other complement-mediated conditions.
The Company has subsidiaries in the UK (Complement Therapeutics Ltd) and in the USA (Complement Therapeutics Inc) as well as research laboratories in Stevenage, UK.
About Geographic Atrophy Geographic Atrophy (GA) is a leading cause of blindness in the elderly and represents the advanced stage of dry age-related macular degeneration. It is characterised by the progressive degeneration of photoreceptors, retinal pigment epithelium, and choriocapillaris, resulting in irreversible vision loss. GA affects over 5 million people globally and remains a significant unmet clinical need.
Rating Reviews
Rating is calculated based on
1
review and is evolving.
Pros: The collaborative atmosphere and the dedication of colleagues are definite high points. It's rewarding to be part of a company focused on innovative treatments in the rare disease space. There's a genuine sense of contributing to something meaningful, and the work environment fosters learning and professional development.
Cons: As with many startups, communication can sometimes be a bit fragmented, especially across different project teams. During peak periods, workload can be challenging, and sometimes processes feel a bit ad-hoc. More structured project planning could help streamline operations.
Advice to Management: Consider implementing more formal project management tools and communication channels to ensure alignment across all teams, especially as the company grows. Clearer roadmaps for career progression would also be beneficial.
Show more
How is the salary range for a Research Scientist role at Complement Therapeutics in Boston?
Based on my experience as a Research Scientist in the biotech industry in Boston, salaries for roles like this at a company like Complement Therapeutics typically range from $100,000 to $150,000 annually, depending on experience and specific qualifications.
DE
